Index of authors for abstracts accepted at BOPSS 2018, Dublin. Click here for full abstract listings.
The numbers refer to abstracts of submitted free papers. First authors are indicated in bold.
Abstracts starting with number 1 are presented on Thursday, click here to view detailed schedule
Abstracts starting with number 2 are presented on Friday, click here to view detailed schedule
Abstracts starting with number 3 & 4 refer to ePoster presentations.
Please note that this list is auto-generated from the abstract submissions based on surnames, so differences in the initials entered can lead to duplicate entries and where authors share surnames then the abstract details should be checked by clicking on the abstract number to verify the exact author.
This is a list of accepted authors and presentations. It assumes that all accepted will attend and present
| Title | Orbital Rhabdomyosarcoma: Late Effects |
| Submitted by | Conor Malone |
| Abstract ID | 18-173 |
| Review Result | rapid fire presentation |
| Abstract Number | 204 |
| Purpose | Rhabdomyosarcoma (RMS) is the most common primary orbital malignancy in children and can be both sight-threatening and life-threatening. We present a 40-year retrospective review of orbital RMS in the Republic of Ireland from 1977 to 2017. |
| Methods | The review was carried out at the national referral centre for RMS, including all known cases nationally. 22 cases were identified using coding records, of which 20 available medical charts were reviewed. |
| Results | Median age at presentation was 6.5 years, with a male to female ratio of 3:2. Presenting complaints included eyelid oedema (40%), proptosis (35%), and ptosis (25%). Histopathology confirmed embryonal or alveolar tumours in 80% and 5% of cases, respectively; in 15% of cases no definitive tumour type was documented. 45% of patients treated during the 1990s received chemotherapy according to international protocols; this rose to 85% in the 2000s. 17 patients received radiotherapy, 1 patient received proton beam therapy, and 2 patients did not receive radiotherapy due to their age. Median follow-up was 82 months (range: 32-227 months). 4 patients did not survive. Complications included cataract (70%), dry eye (50%), and enophthalmos (37%). 73% maintained visual acuity of 6/10 or better in the affected eye. |
| Conclusion | In line with international data, a 5-year survival rate of 94% was achieved in localised alveolar disease, the most common form of orbital RMS. Long-term follow up is essential, due to the high likelihood of cataract and ocular surface disease. |
